Merck and Eisai Provide Update on Phase 3 LITESPARK-012 Trial Evaluating First-Line Combination Treatments for Certain ...
The Renal Patients Association of Ghana has urged government to expand dialysis infrastructure nationwide to address rising ...
A triplet regimen comprising Merck’s Welireg and PD-1 blockbuster Keytruda and Eisai’s Lenvima flopped in a Phase 3 renal ...
What began as research aimed at expanding the limited treatment options for cystinuria, a rare genetic disorder affecting 1 ...
After prevailing in two kidney cancer trials in the refractory and early-stage settings, Merck & Co.’s blockbuster prospect ...
Ultomiris has met its primary endpoint in a phase III trial targeting immunoglobulin A nephropathy (IgAN), a rare ...
Elevated LDH predicts worse renal and cardiovascular outcomes in advanced CKD without diabetes. Learn how this biomarker ...
Kura Oncology shares jump 8% as FIT-001 data show strong tumor response and disease control with darlifarnib combination in ...
A milk replacement for puppies is being recalled nationwide, and officials are urging pet owners to discontinue its use ...
COSTA MESA, Calif., April 21, 2026 /PRNewswire/ -- CerraCap Ventures investment in Nephronomics reflects strategic conviction ...
John Gotti’s grandson Carmine Agnello was sentenced to 15 months behind bars for a $1.1 million dollar COVID fraud, as court ...
Bernie Sanders, found that drug companies involved in price deals with President Donald Trump have continued to raise prices on hundreds of medications. Some new drugs are also launching with very ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results